| GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting |
Globe Newswire |
10/26 |
08:00 |
| Optery Wins Transformational Anti-Phishing Award in Cyber Defense Magazine’s Top InfoSec Innovators Awards for 2026 |
Globe Newswire |
10/26 |
08:00 |
| Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer |
Globe Newswire |
10/26 |
08:00 |
| Genius Group Launches GENIUSpark to Build and Operate Community-First AI Data Centers, Targeting an Initial 100 MW of AI Compute |
Globe Newswire |
10/26 |
08:00 |
| Enphase Energy and Infineon Announce World’s First 900 V GaN Bidirectional Switch Devices for AI Data Center Solid-State Transformers |
Globe Newswire |
10/26 |
08:00 |
| Seismic Therapeutic to Participate in Upcoming Investor Conferences |
Globe Newswire |
10/26 |
08:00 |
| SEALSQ Announces Intent to Acquire Capacity and Operational Services Associated with 12 WISeSat.Space Satellites for QSOC |
Globe Newswire |
10/26 |
08:00 |
| TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years |
Globe Newswire |
10/26 |
08:00 |
| New Temporary Insurance Website, Temp Insurance UK, Launches for UK Motorists |
Globe Newswire |
10/26 |
08:00 |
| Amaero Announces Date of Third Quarter 2026 Earnings Release and Conference Call |
Globe Newswire |
10/26 |
08:00 |
| Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature |
Globe Newswire |
10/26 |
08:00 |
| Verde Resources Withdraws Form S-1, Reaffirms Nasdaq Uplisting Plans |
Globe Newswire |
10/26 |
08:00 |
| Monte Alto Indicated Ultra-High Grade Mineral Resource Grows by 41% |
Globe Newswire |
10/26 |
08:00 |
| Timbercreek Financial to Release Q3 2026 Results November 11; Conference Call Scheduled November 12 |
Globe Newswire |
10/26 |
08:00 |
| Xpanner Launches X1 Piling R6, Bringing One-Touch Automated Pile Driving to Solar and BESS Construction |
Globe Newswire |
10/26 |
07:59 |
| Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain |
Globe Newswire |
10/26 |
07:55 |
| ROSEN, THE FIRST FILING FIRM, Encourages The Ensign Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ENSG |
Globe Newswire |
10/26 |
07:47 |
| HI-VIEW IP SURVEY IDENTIFIES MULTIPLE POTENTIAL PORPHYRY TARGETS AT THE BLACK PEARL, TOODOGGONE REGION, BRITISH COLUMBIA |
Globe Newswire |
10/26 |
07:45 |
| FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM |
Globe Newswire |
10/26 |
07:30 |
| Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026 |
Globe Newswire |
10/26 |
07:30 |
| Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC |
Globe Newswire |
10/26 |
07:30 |
| Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project |
Globe Newswire |
10/26 |
07:30 |
| 'Austin Marketers Connect' Approaches Capacity - Final Opportunity to Join an Exclusive Gathering of B2B Marketing & Growth Leaders |
Globe Newswire |
10/26 |
07:20 |
| MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer |
Globe Newswire |
10/26 |
07:06 |
| Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026 |
Globe Newswire |
10/26 |
07:05 |
